Home » Authors » Larry Haimovitch

Articles by Larry Haimovitch

Interest in AF continuing to grow among clinicians

May 20, 2008

By Larry Haimovitch

Eyecare titan Alcon sets sights on 'constant' sector leadership

April 11, 2008

By Larry Haimovitch

Steady progress, though no blockbuster developments

March 1, 2008

By Larry Haimovitch

Penumbra offers hopeful data for treating 3rd deadliest disease

Feb. 28, 2008

By Larry Haimovitch

Caffeine/alcohol IV infusion may offer stroke neuroprotection

Feb. 26, 2008

By Larry Haimovitch

Penumbra offers hopeful data for treating 3rd deadliest disease

Feb. 25, 2008

By Larry Haimovitch

AF: The heart disturbance that continues to disturb heart surgeons

Feb. 1, 2008

By Larry Haimovitch

Ophthalmology rides growing wave in IOL market sector

Feb. 1, 2008

By Larry Haimovitch

Ophthalmology riding growing wave in intraocular lens sector

Jan. 25, 2008

By Larry Haimovitch

Controversy, uncertainty cast large shadows over AF ablation

Jan. 23, 2008

By Larry Haimovitch

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.